PLG EMEA: Where Our Global Network Began
Europe, the Middle East and Africa are where ProductLife Group was founded, and where our network remains most extensive. With teams across France, Germany, Switzerland, the UK & Ireland, Belgium & the Netherlands, Italy, Spain, Portugal, the Czech Republic, Romania, the Nordic and Baltic countries, and Africa, PLG EMEA gives life sciences companies local expertise in each market, working as a single integrated organization.
We support pharmaceutical, biotechnology, medical device, diagnostics, consumer health, and cosmetics companies across the full product lifecycle: from development and regulatory approval through market access, compliance, and digital transformation. [X]+ experts across the region work within one delivery model. Every recommendation is owned by a senior expert, and intelligent automation speeds up their work without replacing their judgment.
Whether you are preparing a centralized EU submission, launching across multiple European markets, meeting post-market obligations, or expanding into the Middle East and Africa, our teams work as an extension of yours to simplify complexity at every stage.
Expert Guidance for Navigating the Complexities of EMEA
EMEA combines one of the world's most harmonized regulatory systems with some of its most fragmented markets. A single EU marketing authorization can still lead to 27 different pricing, reimbursement, and access pathways. The UK and Switzerland each have their own regulatory frameworks, and markets across the Middle East and Africa differ widely in their requirements, timelines, and healthcare systems.
Companies must also keep pace with a changing regulatory landscape. This includes the EU Health Technology Assessment Regulation and Joint Clinical Assessments, the continued implementation of MDR and IVDR, stricter data integrity and pharmacovigilance expectations, and the evolving EU pharmaceutical framework.
PLG EMEA helps organizations manage this complexity by combining country-level knowledge, multilingual teams, and regional coordination. Because our experts work across borders, clients get a consistent strategy and execution across markets without having to manage a patchwork of local providers.
What We Deliver Across the Lifecycle
Regulatory approval is one milestone. Keeping a product compliant and accessible to patients across dozens of markets is ongoing work.
We partner with clients to:
- Develop and execute regulatory strategies for EMA, MHRA, Swissmedic, and national competent authority procedures.
- Prepare for EU Joint Clinical Assessments and build national market access, pricing, and reimbursement strategies.
- Advance CMC, clinical, and non-clinical development programs, including biologics and advanced therapies.
- Deliver pharmacovigilance, EU QPPV, and local safety services, including multilingual literature screening.
- Support medical device and IVD compliance under MDR and IVDR.
- Strengthen quality systems, GxP compliance, audits, and inspection readiness.
- Design and qualify manufacturing facilities, cleanrooms, and smart manufacturing systems.
- Modernize operations through computerized system validation, data, automation, and AI-enabled solutions.
- Manage regulatory operations, medical information, and lifecycle maintenance across multiple markets.
For companies headquartered outside EMEA, we provide the local presence and expertise needed to enter and grow in Europe and beyond. For EMEA-based companies, our teams in North America and Asia-Pacific support expansion into the US, Canada, Japan, Australia, and other strategic markets.
Regional Network & Group Brands
Through ProductLife Group's EMEA network, clients gain access to specialized expertise across:
- Regulatory Affairs & Regulatory Operations
- Pharmacovigilance, QPPV & Medical Information
- Quality, Compliance & Inspection Readiness
- Market Access, Pricing, Reimbursement & HEOR
- Clinical & Non-Clinical Development
- CMC & Biologics Advisory
- Pharmacometrics & Model-Informed Drug Development
- Medical Devices & Diagnostics (MDR/IVDR)
- Cosmetics, Food Supplements & Borderline Products
- Engineering, Qualification & Validation
- Smart Manufacturing & Digital Transformation
- Healthcare Strategy & Policy Advisory
Our regional presence draws on specialized Group Brands that joined PLG. Each brings in-depth expertise in its field and strong local roots.
Why Clients Choose PLG in EMEA
- Unmatched Regional Footprint
Direct presence in more countries across EMEA than in any other region, with local experts who know each authority, market, and healthcare system. - One Partner, Many Markets
One accountable team coordinating strategy and execution across borders, so multi-country programs remain consistent and efficient. - End-to-End Lifecycle Coverage
From development and engineering to market access, compliance, and digital innovation: every stage of the product journey covered by one integrated organization. - Senior Expertise, Amplified by Technology
Every recommendation is owned by a senior life sciences expert. Intelligent automation accelerates their judgment; it never replaces it. - Flexible Engagement Models
From targeted expert support to fully outsourced functions, tailored to emerging biotechs, mid-sized companies, and global pharmaceutical and medtech organizations.
Supporting Life Sciences Organizations Across EMEA
PLG EMEA supports organizations across:
- Pharmaceutical & Biopharmaceutical Products
- Biotechnology
- Medical Devices & Diagnostics
- Consumer Healthcare
- Cosmetics & Food Supplements
- Combination Products
- Advanced Therapies & Cell and Gene Therapies
- Digital Health & Software as a Medical Device (SaMD)
Whether you are preparing a submission, launching across Europe, managing ongoing compliance obligations, or expanding beyond the region, PLG EMEA helps simplify complexity so you can focus on bringing innovation to patients.
